These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 17034979

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of polymers in moisture sorption and physical stability of polymorphic olanzapine.
    Paisana MC, Wahl MA, Pinto JF.
    Eur J Pharm Sci; 2017 Jan 15; 97():257-268. PubMed ID: 27908675
    [Abstract] [Full Text] [Related]

  • 27. A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetam.
    Croker DM, Hennigan MC, Maher A, Hu Y, Ryder AG, Hodnett BK.
    J Pharm Biomed Anal; 2012 Apr 07; 63():80-6. PubMed ID: 22333478
    [Abstract] [Full Text] [Related]

  • 28. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation.
    Varasteh M, Deng Z, Hwang H, Kim YJ, Wong GB.
    Int J Pharm; 2009 Jan 21; 366(1-2):74-81. PubMed ID: 18840515
    [Abstract] [Full Text] [Related]

  • 29. Solid state characterization of spray-dried powders of recombinant human deoxyribonuclease (rhDNase).
    Chan HK, Gonda I.
    J Pharm Sci; 1998 May 21; 87(5):647-54. PubMed ID: 9572918
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. An investigation into the morphology of loxapine in a thermal aerosolization process from crystalline to amorphous.
    Gao Q, Lew A, Takahashi LH, Cassella JV.
    J Pharm Sci; 2011 Apr 21; 100(4):1407-15. PubMed ID: 20963844
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E, Curzi M, Giaffreda SL, Grepioni F, Maini L, Braga D.
    J Pharm Pharmacol; 2015 Jun 21; 67(6):823-9. PubMed ID: 25644936
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Polymorphism in nimodipine raw materials: development and validation of a quantitative method through differential scanning calorimetry.
    Riekes MK, Pereira RN, Rauber GS, Cuffini SL, de Campos CE, Silva MA, Stulzer HK.
    J Pharm Biomed Anal; 2012 Nov 21; 70():188-93. PubMed ID: 22795312
    [Abstract] [Full Text] [Related]

  • 40. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
    Agnihotri SA, Aminabhavi TM.
    J Control Release; 2004 Apr 28; 96(2):245-59. PubMed ID: 15081216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.